- Home
- ETON vs BRT Comparison
ETON vs BRT Comparison
Compare ETON & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | BRT |
|---|---|---|
| Founded | 2017 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.8M | 285.9M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ETON | BRT |
|---|---|---|
| Price | $16.87 | $14.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $29.67 | $19.75 |
| AVG Volume (30 Days) | ★ 220.3K | 57.0K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 6.79% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $70,316,000.00 | ★ $98,001,000.00 |
| Revenue This Year | $107.23 | N/A |
| Revenue Next Year | $29.72 | $3.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 102.77 | 1.30 |
| 52 Week Low | $11.09 | $14.00 |
| 52 Week High | $23.00 | $19.01 |
Technical Indicators
Market Signals| Indicator | ETON | BRT |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 49.99 |
| Support Level | $16.53 | $14.18 |
| Resistance Level | $17.33 | $14.86 |
| Average True Range (ATR) | 0.59 | 0.25 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 66.46 | 45.21 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.